iShares Dow Jones U.S. Pharmaceutical Index Fund | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (39)

View All

Latest Posts

About This Stock More About This Stock
3 Beaten-Down ETFs To Buy For A Turnaround In 2024
Article By: Zacks Investment Research
Friday, December 22, 2023 10:00 PM EDT
Following three consecutive monthly losses since the COVID pandemic began in March 2020, Wall Street recorded a robust recovery starting in November. we have highlighted ETFs from different zones that have plunged the most over the past three months
In this article: HDV, DVY, IEO, IHE
Read
5 Secret Santa ETFs That Might Surprise You This Christmas
Article By: Sweta Killa
Saturday, December 16, 2023 10:00 AM EDT
Wall Street has been sizzling hot this holiday season. This is likely to continue, given that the Santa Claus rally is on the way. Against such a backdrop, there are some hidden gems which could surprise investors with big returns this Christmas.
In this article: DHS, IHE, IHF, IYE, SDY
Read
3 Sector ETFs That Beat The Market Last Week
Article By: Sweta Killa
Monday, August 14, 2023 2:36 PM EDT
Here are three ETFs from different sectors that were in green last week.
In this article: IHE, PXE, URNJ
Read
J&J ETFs To Gain On Upbeat COVID-19 Vaccine Data
Article By: Zacks Investment Research
Saturday, September 25, 2021 6:00 AM EDT
Johnson & Johnson has again announced positive data highlighting the efficiency of its single-shot COVID-19 vaccine in providing protection against COVID-related hospitalizations.
In this article: JNJ, IHE, IYH, XLV, FTXH, IEIH
Read
Will Pfizer ETFs Soar On FDA's COVID-19 Vaccine Booster Approval?
Article By: Zacks Investment Research
Friday, September 24, 2021 6:30 AM EDT
Investors have one more reason to cheer the COVID-19 vaccine update as the FDA has approved emergency use of a booster dose of the Pfizer Inc. and BioNTech SE COVID-19 vaccine.
In this article: FDL, IHE, PJP, IEIH Also: PFE, MRNA, BNTX
Read
All Posts

Latest Tweets for $IHE

No tweets yet!

PARTNER HEADLINES